Abstract |
Many knowledgeable people believe that the only real hope for halting the AIDS pandemic rests with safe and effective HIV vaccines that are delivered through a global immunization programme. When such vaccines become a reality, the size of potential target populations for HIV vaccines may well be over 100 million. The costs associated with such a large vaccination programme probably reach the multi-billion dollar level. An international consideration of financing strategies should begin in the near future in order to avoid a repetition of the lag between vaccine availability and widespread use that accompanied the introduction of hepatitis B vaccine.
|
Authors | J C Petricciani |
Journal | Vaccine
(Vaccine)
Vol. 11
Issue 8
Pg. 873-7
( 1993)
ISSN: 0264-410X [Print] Netherlands |
PMID | 8356848
(Publication Type: Journal Article)
|
Chemical References |
|
Topics |
- AIDS Vaccines
(economics, therapeutic use)
- Acquired Immunodeficiency Syndrome
(economics, prevention & control)
- Humans
- Immunization
(economics)
- International Cooperation
|